Sort
21,453 grants matching “tuberculosis”
Mechanisms mediating adverse birth outcomes in the context of S. Japonicum infect
$105,195Jennifer F Friedman · Rhode Island Hospital · K02 · FY2009 · AI
Mathematical Techniques for Control of Epidemic Trypanosoma cruzi Transmission
$105,194Michael Z Levy · University Of Pennsylvania · K01 · FY2011 · AI
Mathematical Techniques for Control of Epidemic Trypanosoma cruzi Transmission
$105,194Michael Z Levy · University Of Pennsylvania · K01 · FY2012 · AI
Antibodies associated with protection against tuberculosis in nonhuman primates
$105,153Jacqueline Michele Achkar · Albert Einstein College Of Medicine, Inc · R21 · FY2018 · AI
Tuberculosis Elimination and Laboratory Cooperative Agreement
$105,138Phillip Griffin · Kansas State Dept Of Hlth And Environmnt · U52 · FY2016 · PS
Dolutegravir for the treatment of HIV in patients with Tuberculosis in KwaZulu-Natal South Africa
$105,079Anushka Naidoo · Centre/Aids Programme/Res/South Africa · K43 · FY2020 · TW
Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis.
$104,695Karen Du Preez · Stellenbosch University · K43 · FY2021 · TW
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network Study
$104,640Sarita Shah · Emory University · R01 · FY2021 · AI
Defining the biology of HIV-associated aggressive B-cell lymphoma in Southern Africa
$104,575Katherine Antel · University Of Cape Town · K43 · FY2022 · TW
Training in Host-pathogens interactions
$104,564David M Mosser · Univ Of Maryland, College Park · T32 · FY2010 · AI
Mechanisms mediating adverse birth outcomes in the context of S. Japonicum infect
$104,490Jennifer F Friedman · Rhode Island Hospital · K02 · FY2008 · AI
Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers
$104,391Richard F. Ambinder · Johns Hopkins University · R01 · FY2023 · CA
Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers
$104,391Richard F. Ambinder · Johns Hopkins University · R01 · FY2022 · CA
Program/Project Administrative
$104,367William Robert Jacobs · Albert Einstein College Of Medicine, Inc · P01 · FY2015 · AI
Training in Translational Lung Research
$104,345Neil W. Schluger · Columbia University Health Sciences · T32 · FY2008 · HL
Dynamic allosteric communication within nonribosomal peptide synthetase cyclization domains
$104,280Dominique Pascal Frueh · Johns Hopkins University · R01 · FY2021 · GM
ALVEOLAR MACROPHAGE INNATE IMMUNE FUNCTION IN HIV
$104,245Beth Israel Deaconess Medical Center · R01 · FY2002 · HL
M. tuberculosis exosome detection for pediatric TB diagnosis
$104,166Sylvia Lacourse · University Of Washington · R01 · FY2025 · AI
Characterizing Macrophages as "Hide-Outs" for Chronic Pathogens
$104,091Kiera L. Clayton · Univ Of Massachusetts Med Sch Worcester · DP2 · FY2024 · AI
Transitioning to a National Infectious Diseases Institute in Tanzania
$104,082Amber Steen · University Of Virginia · G11 · FY2024 · TW
PLA2R1 Loss-of-Function: A Monogenic Cause of Sarcoidosis in African-Americans in the ACCESS Cohort
$104,068Dorin-Bogdan Borza · Meharry Medical College · R21 · FY2024 · HL
PERUVIAN MEDICINAL PLANT SOURCES OF NEW PHARMACEUTICALS
$104,000Washington University · U01 · FY2000 · TW
Glycopeptides and Other Non-Natural Variants: Probes of Carbohydrate Function
$103,992Laura L Kiessling · University Of Wisconsin-Madison · R01 · FY2012 · GM
Safe Pregnancy by Infectious Disease Control in Kinshasa
$103,990University Of North Carolina Chapel Hill · U01 · FY2005 · HD
Early Preclinical Testing of TB Drugs in Mice
$103,876Colorado State University-Fort Collins · P01 · FY2004 · AI